Polpharma Biologics International AG
1 clinical trials · Sponsor
◉ Watch Polpharma Biologics International AG
| Record | Firm | Date |
|---|---|---|
| A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus (NCT07606521) | Polpharma Biologics International AG | 2026-10-01 |
Track Polpharma Biologics International AG automatically
Every clearance here is in the API, with alerts when new ones post.